Consistently, data analysis from TCGA cohort or ICGC-LIRI-JP cohort also revealed that ACLY overexpression was correlated with poor prognosis of HCC patients (Fig. 1E and Supplementary Fig. S1C). This evidence concerns the gene ACLY and hepatocellular carcinoma.